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Disruption of the potassium/chloride cotransporter 3 (KCC3), encoded by the SLC12A6 gene, causes hereditary motor and sensory
neuropathy associated with agenesis of the corpus callosum (HMSN/ACC), a neurodevelopmental and neurodegenerative disorder
affecting both the peripheral nervous system and CNS. However, the precise role of KCC3 in the maintenance of ion homeostasis in the
nervous systemand the pathogenicmechanisms leading toHMSN/ACC remain unclear.We established two Slc12a6Cre/LoxP transgenic
mouse lines expressing C-terminal truncated KCC3 in either a neuron-specific or ubiquitous fashion. Our results suggest that neuronal
KCC3 expression is crucial for axon volume control.We also demonstrate that the neuropathic features ofHMSN/ACCare predominantly
due to a neuronal KCC3 deficit, while the auditory impairment is due to loss of non-neuronal KCC3 expression. Furthermore, we
demonstrate that KCC3 plays an essential role in inflammatory pain pathways. Finally, we observed hypoplasia of the corpus callosum in
both mouse mutants and a marked decrease in axonal tracts serving the auditory cortex in only the general deletion mutant. Together,
these results establish KCC3 as an important player in both central and peripheral nervous systemmaintenance.
Introduction
Hereditary motor and sensory neuropathy associated with agen-
esis of the corpus callosum (HMSN/ACC; Online Mendelian In-
heritance in Man No. 218000) is a severe and progressive
autosomal-recessive polyneuropathy associated with hypotonia,
mental retardation, dysmorphism, variable degrees of agenesis of
the CC, and visual/auditory hallucinations, resulting in death
typically during the third decade (Dupre´ et al., 2003). Our group
previously reported that the K/Cl cotransporter 3 (KCC3),
encoded by the SLC12A6 gene, is disrupted in patients with this
disorder (Howard et al., 2002). KCC3 belongs to a family of four
K/Cl cotransporters that have crucial roles in ion homeosta-
sis, cell volume regulation, and modulation of the cellular re-
sponses to GABA during neuronal development (Kahle et al.,
2008). Structurally, KCC3 has 12 transmembrane domains and
both the N and C termini extend into the cytoplasm (Hiki et al.,
1999). The predominant mutation found in HMSN/ACC pa-
tients consists of a G deletion at the conserved GT splice donor
site of exon 18, leading to both aberrant splicing and creation of a
novel stop codon at position 813 of the protein (Thr813X), thus
prematurely removing most of the C-terminal portion of the
protein (338 aa). This suggests that the KCC3C-terminal domain
has an important function. Indeed, phosphorylation of the
C-terminal domain was recently shown to play a regulatory role
in controlling cell volume (Rinehart et al., 2009).
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Neuropathological examinations of postmortem material
from HMSN/ACC patients, and previous KCC3 knock-out ani-
mal data demonstrate axonal swelling and thin myelin sheaths in
peripheral nerves (Howard et al., 2002; Boettger et al., 2003; Du-
pre´ et al., 2003). However, whether axonal swelling is a result of
damage to the axons or to the myelinating Schwann cells re-
mained unknown. The high incidence (58%) of ACC observed
in individuals with HMSN/ACC (Mathieu et al., 1990) indicates
that KCC3 may play an essential role in the proliferation and/or
survival of non-neuronal midline structures that help guide
midline-crossing axons. KCC3 may also play a role in the main-
tenance and/or motility of long axon projections. Although the
genetic deletion of Slc12a6 in mouse models was previously
shown to produce a phenotype comparable to the disorder ob-
served in humans (Howard et al., 2002; Boettger et al., 2003), the
cell types responsible for the different pathological phenotypes
have not been dissected.
In the present study, we generated a transgenic mouse line
(Slc12a6flox/flox) with LoxP sequences flanking exon 18, allowing
tissue-specific deletion of exon 18 that closely mimics the human
Thr813X mutation. Using lines expressing Cre recombinase, we
generated ubiquitous (Slc12a618/18) and neuron-specific
(nsSlc12a618/18) KCC3-null mice. Adult mice from both lines
had a very similar phenotype during locomotor activity or pain
tests, thus supporting a critical role for KCC3 in the nervous
system. However, auditory defects observed in the Slc12a618/18
but not the nsSlc12a618/18 line suggest a non-neuronal role for
KCC3 in auditory sensory perception. High-resolution magnetic
resonance imaging reveals hypoplasia (dysgenesis) of the corpus
callosum in both mice mutants and a substantial decrease in
white matter integrity proximal to the auditory cortex only in
Slc12a618/18 mice.
Materials andMethods
Generation of floxed Slc12a6 and KO mice. Murine Slc12a6 cDNA se-
quences are available [GenBank accession numbers AF211854
(mKCC3a) and AF211855 (mKCC3b)]. To obtain the Slc12a6 genomic
DNA regions containing exon 18 and its flanking sequences, we PCR
amplified three separate fragments from total genomic DNA isolated
from mouse line 129/Sv: one 1.2 kb fragment containing exon 17 (5
arm), one 770 bp fragment encompassing exon 18, and one 2 kb frag-
ment containing exons 19 and 20 (3 arm). Tomake a targeting construct
for homologous recombination, the fragments containing the 5 arm,
exon 18, and the 3 arm were subcloned into the pDELBOY-3X vector
(Rossi et al., 2001; Korsisaari et al., 2002). The construct also contained a
phosphoglycerate kinase (PGK) promoter-driven neomycin resistance
cassette (neo, used as a positive selectionmarker) flanked by the 5 armof
homology and the targeted exon 18 of Slc12a6, as well as a PGK-driven
thymidine kinase gene from HSV (used as a negative selection marker),
which lies downstream from the 3 arm of homology. The neo cassette
was closely flanked by two frt sites, and two loxP sites, which were also
introduced into intronic sequences, one downstream from the 5 arm of
homology, right before the neo cassette, and the other between the target
exon and the 3 arm of homology. All constructs and DNA fragments
were sequenced at each step and checked for correct orientation of
fragments.
The linearized targeting vector was electroporated into the ES cells,
since recombination rates have been shown to increase with the use of
isogenic vector DNA (te Riele et al., 1992), the same line was used for
electroporation of the construct. The cells were grown in double selection
media and were screened for positive clones by Southern blot or PCR.
Two sets of primers were used to verify the 5 and 3 arms for correct
recombination: For 5 probe (size 785 bp), a forward primer (F: CAGC-
CTCCAAAACTGGGAATGAA) located upstreamof the 5 armwas used
in combination with a reverse primer (R: AAGACTCGAGTTCTGCAG-
TACTTTGAATGTTCTCAG) located within the neo cassette. To verify
the 3 end (template size 213 bp), a forward primer (F: TGCAGTGGGC
AGCAGTT) was designed to anneal within the target sequence in exon
18, while the reverse primer (R: ATTATTCCTGGTTTTAAGTTCTT)
was located downstream from the 3 arm of homology. For the 3 end
PCR, a KpnI digestion step was added that creates a novel band of 2.3 kb
visible by agarose gel electrophoresis in correctly recombined positive
clones (instead of an uncut 2.6 kb band). Following electroporation of
the vector into the ES cell, two correctly targeted ES cell clones were
identified, 1E6 and 2C6, from1400 clones screened. The two correctly
targeted ES cell cloneswere injected intoC57BL/6mouse blastocysts, and
the resultant animals were screened using standard methods. All the
experiments reported here were performed with animals that were de-
rived from only one of these two clones (1E6).
List of the primers used for characterization of Slc12a6 mouse lines. To
screen LoxP/LoxP, F: CAGGCTTCCAAGGCCAGCACTGC and R: CC
TCCGAGGCCACAGGACTGGAT were used. To screen exon 18 dele-
tions, two sets of primers—F: ATTCTCAGTATTGTTTTGCCAAGTTC
T,R:CTTAATCTGATGATCCTGGAAGTTTTAandF:CAGGCTTCCA
AGGCCAGCACTGC, R: CCTCCGAGGCCACAGGACTGGAT—were
used. To screen PCX-Cre, F: AAGAGGGACAGCTATGACTGG and R:
GTGTCTCTCACTCGGAGGGA were used. To screen Syn1-Cre, F: AG
GGAGTTTCGTTACTACAGGTCCandR:AGATTGGCCATGAAGTTG
CTGTCC were used.
Mouse lines and crosses. All animal experiments were approved by local
animal care and use committees at the Centre Hospitalier de l’Universite´ de
Montre´al or McGill University. To obtain a pure line, Slc12a6flox/flox trans-
genicmicewerebredwithC57BL/6 for at least six generations.Slc12a6 flox/flox
homozygous mice were mated once with those from a transgenic line ex-
pressing a Cre recombinase under the control of the chicken -actin pro-
moter (pCX-NLS-Cre, kindly provided by the Nagy Laboratory, University
of Toronto, Toronto, ON, Canada) to generate a mouse line in which
Slc12a6 was ubiquitously knocked out (Slc12a618/18). A separate mouse
line expressing Cre recombinase under the control of synapsin I regulatory
elements (Syn1-Cre, kindly provided by J.-F. Cloutier, McGill University,
Montre´al, QC, Canada) was used to ablate Slc12a6 expression in a neuron-
specific manner (nsSlc12a618/18). The Slc12a6 flox/; crepCX or Slc12a6 flox/;
cresyn1 heterozygous mice were then intercrossed to obtain ubiquitous or
neuron-specific KO lines, Slc12a618/18 or nsSlc12a618/18, respectively.
Since the excision of exon 18 occurs in the germ line, it was not necessary to
obtain a line homozygous for the crepCX allele. Furthermore, no differences
in phenotype were observed in Slc12a618/18 lines with or without the
crepCX allele or between the genders. At least five different pairs ofmice were
used to obtain the test animals for each dataset of the experiments.
Reverse transcriptase-PCR, Western blot. RT-PCR was performed using
standard protocols using the primers F:GGTAATAGCTGGCATGATCTA-
CAAG, R: TGCACAATCCACCACACATCAAT, and as described previ-
ously (Shekarabi et al., 2008). SDS-PAGE was performed on crude brain
lysates from mouse brain and kidney. Anti-KCC3 (H00009990-A01, Ab-
nova, 1:1000), anti-tubulin (MAB1637, Millipore Bioscience Research Re-
agents, 1:1000), and anti-actin (MAB1501, Millipore Bioscience Research
Reagents, 1:3000) antibodies were used.
Immunohistochemistry and Epon sections. All immunohistochemistry
and tissue preparations were performed as described previously (How-
ard et al., 2002; Shekarabi et al., 2008). A mix of anti-axonal markers
SMI31 and SMI32 (Covance, each at 1:500), anti-glutamic acid decar-
boxylase (GAD67; Novus Biologicals, 1:200) followed by donkey anti-
mouseAlexa Fluor 488 or anti-rabbit Alexa Fluor 488 (Molecular Probes,
all at 1:1000) were used to label axons (Shekarabi et al., 2008), and
GABAergic neurons and synaptic terminals, respectively. FlouroMyelin
dye (Molecular Probes, 1:300) was used to label myelin. Immunohisto-
chemistry was performed on fixed E17 or P0 of WT, Slc12a618/18, and
nsSlc12a618/18 brain sections, which were cut at 50 m on a Leica
Vibratome. Primary antibodies were incubated at 4°C overnight, and
included rabbit polyclonal anti-glial fibrillary acidic protein (GFAP;
DAKO, 1:30,000) and mouse monoclonal anti-growth associated
protein-43 (GAP-43; Millipore Bioscience Research Reagents, 1:10,000),
anti-Nfia (nuclear factor 1-A; Active Motif, 1:20,000), and anti-Satb2
(Abcam, 1:10,000). Secondary antibodies were incubated at room tem-
perature for 1 h and included goat anti-rabbit biotin-conjugated second-
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ary antibody (Vector Labs) and donkey anti-mouse biotin-conjugated
secondary antibody (Jackson ImmunoResearch) at 1:1000 each, followed
by avidin-biotin amplification (PK-6100, Vector Labs) and 3,30-DAB
(Sigma-Aldrich) visualization. Meyer’s hematoxylin (Sigma-Aldrich)
was used as a counterstain.
Primary cortical cultures. Dissociated cortical neurons were prepared
from neocortices of Slc12a6D18/D18 KO and WT animals at E15.5 and
essentially prepared as described previously (Shekarabi and Kennedy,
2002). The neurons were allowed to grow processes for 4 d. They were
then fixed and immunolabeled with an antibody against neurofilament
M (Covance, 1:2000). The axon lengths were measured essentially as
described previously (Shekarabi and Kennedy, 2002).
Open-field, motor coordination, and startle response tests. Rotarod and
beam tests were performed as previously described (Howard et al., 2002).
Open-field locomotor activity was assessed in 5-month-old mice in a
bank of eight Versamax Animal Activity Monitor chambers (Model
RS2USB v4.00, Accuscan). Each chamber consisted of a clear acrylic open
field (40 40 30 cm high), divided into two equal-sized chambers by
an acrylic partition and was covered by an acrylic lid with air holes.
Activity was detected via a grid of infrared photo sensors spaced 2.5 cm
apart and 6 cm above the floor along the perimeter of the box. An addi-
tional bank of 16 photo beams was located 17 cm above the floor and
measured vertical activity (i.e., rearing). Mice were individually placed
into a chamber, and locomotor activity was recorded for a period of 90
consecutive minutes. Total distance, the number of discrete movement
bouts (i.e., periods of activity separated by at least 1 s), and stereotypy counts
(i.e., repetitive breaks of the same beam)were cumulated over the 90min of
the test session. The acoustic startle reflex was measured using six startle
Figure 1. Generation of Slc12a6 flox/flox transgenic mice. A, Schematic representation of mouse genomic DNA encompassing exons 15–20 of the Slc12a6 gene, the targeting construct and
selectionmarkers, and the predicted recombination between the 5 and 3 arms of the construct and the genomic Slc12a6DNA. Themodified allele contains LoxP sites (‹) in introns 17 and 18. The
PGK-neo cassette was also flanked with Frt sequences () and resides in intron 17 in the same orientation. Arrows (3) indicate primers used for PCR or to generate probes for Southern blot
screening of ES clones and animals. P, PstI; Xb, XbaI; B, BamHI; K, KpnI; S, SalI; X, XhoI.B, C, Southern blot analysis and PCR screening experiments used to identify 5 and 3 targeted recombination
in positive clones using probes and specific primers (seeMaterials andMethods).D, A representativeWestern blot analysis of brain and kidney lysates from Slc12a6 flox/flox transgenic animals andWT
littermates probed with anti-KCC3 antibody or anti-tubulin antibody (n 3).
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chambers (San Diego Instruments). Each con-
sisted of a Plexiglas enclosure mounted on a
Plexiglas base within a sound-attenuating cham-
ber. A piezoelectric strain meter attached to the
base transduced the startle response. Stabilimeter
readings were rectified, digitized, and recorded
by a computer. A speaker located in the ceiling of
the sound-attenuating chamber presented all
acoustic stimuli andmaintained a constant back-
ground noise level of 70 dB. Animals were placed
into thePlexiglas enclosureof the startle chamber
for a 5 min acclimatization period, after which
theywere exposed to a total of 36presentationsof
an acoustic startle stimulus (30 ms). Stimuli
ranged between 80 and 120 dB, in 5 dB incre-
ments. There were four trials at each of the nine
intensities.Anaverageof 501ms readings, begin-
ningat stimulusonset,wasusedas themeasureof
startle amplitude for each trial. Trials were pre-
sented randomly, with the on restriction that no
more than two consecutive trials with the same
stimulus intensity were presented in succession.
Trialswere separatedbyavariable intertrial inter-
val that averaged 15 s. The startle chambers were
cleanedwith a 70% alcohol solution between an-
imals. For data analysis, the average of the four
trials at each intensitywas takenas themeasureof
startle reactivity.
Formalin test. A single cohort of mice
[Slc12a6flox/flox (n 6) and Slc12a618/18 (n
8), on their WT littermates (n 6 and n 14,
respectively); and nsSlc12a618/18 (n  8)
with its WT littermates (n  7)] was tested.
Approximately equal numbers of male and fe-
male mice were tested; no significant sex or
sex  genotype interactions were observed.
An additional cohort of WT and conditional
KO (cKO)mice (n 3–4/genotype) was also
tested with the formalin test to confirm the
apparent phenotype. A sampling strategy
was used to quantify pain behavior (Lang-
ford et al., 2006), such that 5 s of every 1 min
period was assessed for the presence or ab-
sence of licking behavior directed at the in-
jected hindpaw.
Analysis of agenesis of the corpus callosum and
anterior commissure. Tomeasure the size of the
corpus callosum, we used a well established
technique of gold chloride staining of the mid-
sagittal plane (Wahlsten et al., 2003). Animals
fromdifferent genotypes, all with C57BL/6 backgrounds, were compared
with their WT littermates. Two-month-old male and female mice were
perfused as described previously (Shekarabi et al., 2008), and the brains
were dissected out, weighed, and split in the midsagittal plane. The gold
chloride staining of myelinated axons was performed as described previ-
ously (Bishop and Wahlsten, 1999; Wahlsten et al., 2003). The sagittal
cutting face of right hemispheres of all brains was photographed using a
Leica DFC 320 camera mounted on a LeicaMZ 12.5 stereomicroscope at
the same magnification. The length of the corpus callosum (CCL) and
the surface area of the anterior commissure (AC) were quantified using
ImageJ software (Abramoff et al., 2004) by tracing anterior commissure
and the corpus callosum. Because the size of the corpus callosum corre-
lates with brain weight, the length was adjusted to the brain weight aver-
age in that group using the linear equationYY b (XM ), whereY
was the adjusted size, Y was the size, b was the slope, X was the brain
weight, and M was the average brain weight (Bishop and Wahlsten,
1999). The spleniumwas defined as the posterior 20% of the total corpus
callosum length, which was established as the boundary between axons
from the visual and parietal cortices in rat (Kim et al., 1996; Kim and
Juraska, 1997). The genu was defined as the anterior 15% (Mack et al.,
1995).
Tractography.Diffusion-weighted MRI and tractography measure the
microstructural properties of white matter tracts and can permit exami-
nation of all tracts within a single brain in three dimensions (Moldrich et
al., 2010). Three-dimensional, diffusion-weighted spin-echo images
were acquired as previously described (Moldrich et al., 2010) using a 16.4
tesla vertical bore, small-animal MRI system (Bruker Biospin; ParaVi-
sion v5.0) and a 15mm linear, surface acoustic wave coil (M2M) at 0.1
0.1 0.1mm(uninterpolated) resolution. Each datasetwas composed of
two b0 values (b value of 0 and 5000 s/mm2, / 2.5/14ms) and 30DW
images. Tractography was performed as previously described (Moldrich
et al., 2010) using MRtrix (Tournier et al., 2007). Streamline number,
fractional anisotropy, diffusivity, and voxel number were obtained for
the rostrum, body, and splenium of the corpus callosum, and were plot-
ted using GraphPad Prism V.4.
Statistics. Behavioral data were analyzed by Student’s t test comparing
responses between genotypes with unpaired Bonferroni adjustment, us-
ing SYSTAT software (v.11). A criterion of 0.05 was used to establish
Figure 2. Characterizationof Slc12a6 conditional KOmouse lines.A, Tail-clasping test doneon Slc12a618/18 andnsSlc12a618/18
KO lines at 3–4weeks of age, comparedwith Slc12a6flox/flox transgenicmice andWT littermates. Resting appearance of Slc12a618/18
and nsSlc12a618/18 mice at 12 months of age exhibiting extensive hindlimb weakness, movement disorganization, and kyphosis
(curvature of the upper spine). B, A representative RT-PCR performed on brain mRNA isolated fromWT and Slc12a618/18mice using
primersdesignedfromexon17(forward)andexon20(reverse).Abandof616bpisseenintheWT,whereasasmallerfragmentof450
bpisseenintheSlc12a618/18mice(n3).C,D,ArepresentativeWesternblotanalysisofbrain lysates isolatedfromSlc12a618/18 (C)
andnsSlc12a618/18 (D)KO linesandtheirheterozygousandWTlittermates (n3),andprobedwithanti-KCC3andanti-actinantibod-
ies. A truncated protein with a molecular weight of75 kDa is weakly visible in the heterozygous and KO animals (arrowheads). E, A
representativeWesternblotanalysisofkidneylysatesfromnsSlc12a618/18andWTlittermatemiceusingthesameantibodiesas inCand
D, showing reducedKCC3 levels, but absence of the truncated KCC3 (n 3).
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statistical significance. One data point was dropped from the formalin
test dataset after being identified as a statistical outlier (SD  3). For
tractography, statistical differences between genotypes were assessed us-
ing two-way ANOVA and Bonferroni’s post hoc t test, where n 3.
Results
Ubiquitous knockout of KCC3 C terminal in mice causes a
severeperipheralneuropathyphenotypesimilar toHMSN/ACC
Toconditionallydisrupt themouseSlc12a6gene inamanner similar
to thehumanThr813Xmutation,we introducedLoxPsitesoneither
side of exon 18 using a pDELBOY-3X targeting vector (Fig. 1A).
Following electroporation of the vector into ES cells, two correctly
targeted ES cell clones were identified, one of which (1E6) was used
to derive the transgenic mice used in further experiments (Fig.
1B,C). We observed 80–85% lower KCC3 expression levels in
Slc12a6flox/flox versus Slc12a6/ littermates using Western blots of
brain lysates probed with an anti-KCC3 antibody (Fig. 1D). The
PGK-neo cassette in intron 17 of Slc12a6flox/floxmay cause this lower
KCC3 protein expression, as previously suggested (Nagy, 2000).
Transgenic Slc12a6flox/flox mice were viable and fertile, and showed
no signs of neuropathy ormotorweakness (Fig. 2A), suggesting that
reduced expression of KCC3 protein in vivo is sufficient for normal
physiological activities.
Figure 3. Analysis of sciatic nerves, assessment of locomotor deficits, and changes in body and brainweights and survival rate of Slc12a6 cKOmice.A, Longitudinal sections of sciatic nerves from
WT, Slc12a618/18, and nsSlc12a618/18 (n 2) were analyzed using immunolabeling with an antibody against axons (SMI31 and 32; green) and amyelinmarker (FlouroMyelin, red). Swollen
axons were observed in both KOs (arrowheads). Semithin cross sections of sciatic nerves were also prepared for histological toluidine blue (TB) staining. Numerous swollen axons with thin myelin
sheets (arrowheads) and axon degeneration (arrows) were observed in both lines when compared with a WT sciatic nerve section. B, C, Results of rotarod and beam-task tests performed on
Slc12a618/18 (n 8) and nsSlc12a618/18 (n 10) mice at 1 and 6 months of age and compared with WT (n 12) and Slc12a6 flox/flox (n 8) littermates. D, Body weights of Slc12a6
conditional KOmice and their respectiveWT littermates were analyzed at 8 weeks of age (n 35). E, The same animals were perfused, and their brains were weighed. A significant increase in the
brain weights of both KO lines was observed, but their bodyweights were decreased. For both brain and bodyweight, the comparisonwasmade using nontransgenic (WT) littermate animals from
each line. F, Both KO lines were alsomonitored for 12months, and their survival rates were calculated using the Kaplan–Meiermethod (n 12). Student unpaired t test; *p	 0.05, **p	 0.005,
***p	 0.001. Data are reported as mean
 SE. Nuclei were stained with TOTO-3 iodide and are shown in blue.
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We crossed Slc12a6flox/flox mice with a
mouse line (pCX-NLS-Cre) that expresses
Cre recombinase in all of its tissues (Nagy,
2000) to produce a line ubiquitously null
for KCC3. The resulting Slc12a618/;
crepCX/ heterozygous animals presented
no abnormalities and were subsequently
intercrossed to generate homozygous
mice, henceforth referred to as the
Slc12a618/18 line. Slc12a618/18 mice
remained viable until adulthood, but ef-
forts to breed them failed, suggesting they
were either infertile or unable to mate. By
3–4 weeks of age, Slc12a618/18 mice de-
veloped progressive neurological defects,
which were evident using a clasping test
(Fig. 2A).
We confirmed deletion of exon 18
and truncation of the KCC3 protein in
Slc12a618/18 mice by RT-PCR and West-
ern blot analysis. RT-PCR analysis using
total brain RNA yielded a lower-molecular-
weight product in Slc12a618/18mice com-
pared with their WT littermates (Fig. 2B).
Sequence analysis confirmed the deletion
of exon 18, predicted to cause a frameshift
leading to premature protein truncation
(Q758LfsX3). Western blot immunodetec-
tion using an antibody against KCC3 (Fig.
2C) revealed several bands of 150 kDa
corresponding to KCC3 in brain lysates
prepared from Slc12a6/ mice. In
Slc12a618/; crepCX/mice,we coulddetect
the150 kDa bands, as well as a number of
lower-molecular-weight bands, whereas in
Slc12a618/18mice only a very faint band at
75 kDa was detected, suggesting that trun-
cated KCC3 is not stable in the cells in vivo
and is likely degradedby intracellular degra-
dation pathways.
Neuron-specific knockout of KCC3 is sufficient to cause
severe neuropathy
To assess the functional role of KCC3 in neurons in vivo, we
crossed Slc12a6flox/floxmice with animals that express Cre recom-
binase under the control of synapsin 1 regulatory elements to
efficiently mediate DNA excision only in neurons (DeFalco et al.,
2001; Zhu et al., 2001). Slc12a618 /; cresyn1mice were viable and
showed no signs of neuropathy. Slc12a618/18; cresyn1 mice were
subsequently generated by intercrossing Slc12a618/; cresyn1
mice. Slc12a618/18; cresyn1 KO mice were viable to adulthood,
but our efforts to breed themwere unsuccessful. Thesemice showed
signs of progressive peripheral neuropathy starting at 3–4 weeks of
age and exhibited a phenotype similar to Slc12a618/18mice in the
clasping test (Fig. 2A). As with the Slc12a618/18 mice, deletion of
exon 18 in these animalswas confirmedbyRT-PCRand sequencing
(data not shown), and reduced levels of the truncated KCC3 were
seen using Western blot analysis of brain lysates (Fig. 2D). Kidney
lysates prepared from these mice also confirmed overall lower ex-
pression of intact KCC3 protein, with no sign of truncated KCC3
(Fig. 2E). Hence homozygous Slc12a618/18; cresyn1mice showed a
neuron-specificKO, and these animalswill henceforthbe referred to
as the neuron-specific (ns) Slc12a618/18 line (nsSlc12a618/18).
Although axon degeneration, hypomyelination, and axon
swelling in the sciatic nerves and the CNS were previously de-
scribed in bothKCC3KOmice andHMSN/ACC cases, the causes
behind these symptoms remain obscure. Using immunohisto-
chemistry and histological staining, we observed significant signs
of axonal degeneration, hypomyelination, and axon swelling in
the sciatic nerves of both KO lines (Fig. 3A). Furthermore, both
lines also exhibited extensive axonal degeneration and increased
axon diameter in longitudinal sections of sciatic nerves labeled with
axon andmyelinmarkers. Cross sections of Epon-embedded sciatic
nerves also corroborated these findings (Fig. 3A). These results
strongly suggest that a neuron-specific ablationofKCC3 is sufficient
toproduceaperipheralneuropathyphenotypesimilar to that seen in
HMSN/ACC patients.
Locomotor and startle response analysis in the conditional
Slc12a6 KOmice
Neurodegeneration in KCC3 KO mice causes a progressive sen-
sory and motor disability that worsens with age. We first mea-
sured the motor coordination and balance of our Slc12a6flox/flox
and both KOs in the rotarod and beam-task tests at 1 and 6
months of age. Both Slc12a618/18 and nsSlc12a618/18 KO an-
Figure 4. Locomotor, startle response, and pain tests in Slc12a6flox/flox, Slc12a6 KO lines, and their WT littermates. A–C, Mean
of the total traveleddistance (A), numberof discretehorizontalmovementbouts separatedbyat least a1 s rest period (B), and total
number of times that a single infrared beamwas broken repeatedly (C) weremeasured in Slc12a6flox/flox (n 7), Slc12a618/18
(n 11), and nsSlc12a618/18 (n 8)mice (gray boxes), and theirWT littermates (n 8, 14, and 7, respectively, black boxes).
D, E, Acoustic startle response was performed in Slc12a6flox/flox (n 6), Slc12a618/18 (n 7), and nsSlc12a618/18 (n 8)
mice, and compared with their WT littermates (n 6, n 10, and n 10, respectively) with increasing stimulus intensities (in
decibels). F–H, Formalin pain tests were performed on Slc12a6flox/flox (n 6), Slc12a618/18 (n 15), and nsSlc12a618/
18(n 14) mice (gray boxes), and their WT littermates (n 6, 13, and 15, respectively, black boxes). Bars represent the
percentage of 5 s samples featuring licking of the injected hindpaw 0–10 min (early phase) and 10–60 min (late phase) after
application of formalin (allmicewere tested at 5–6months of age). *p	 0.05, **p	 0.005, ***p	 0.001. Data are reported as
mean
 SE.
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imals had significantly poor performance in both tests, indicating
severe locomotor deficiencies (Fig. 3B,C). Tests performed at 1
month or 6 months of age were not significantly different for
either line. These results demonstrate that the severity of the
phenotype appears to be stable during the first 6months inKCC3
KOmice. The locomotor deficit in older animals (8 months of
age)was very severe in both lines, andwewere unable to test these
animals in locomotor assays. We measured body and brain
weights in animals from both KO lines at 2 months of age. The
average body weights were 14.1% (p  0.007) and 8.7% (p 
0.011) lower than those of WT littermates for the Slc12a618/18
and nsSlc12a618/18 lines, respectively. However, the average
brain weights of the Slc12a618/18 and nsSlc12a618/18 lines
were 7.2% (p 	 0.001) and 6.4% (p 	 0.001) greater, respec-
tively, than those from WT littermates (Fig. 3D,E). We also
found that Slc12a618/18 mice have a significantly shorter aver-
age lifespan than nsSlc12a618/18mice (6.28 vs 8.86months; p
0.02) (Fig. 3F), suggesting that Slc12a618/18 mice may suffer
from other non-neuronal health problems.
To evaluate spontaneous locomotor activity, we analyzed our
Slc12a6flox/flox, Slc12a618/18, and nsSlc12a618/18 lines at 5
months of age using an open-field test. Surprisingly, we found a
significant increase in the total distance traveled and the number
of movement bouts in bothKCC3KO lines when compared with
their WT littermates. Slc12a6flox/flox animals behaved normally.
Hence, both KO lines exhibit hyperactivity (Fig. 4A–C).
The results of the hyperactive phenotypes seen in both Slc12a6
KO lines prompted us to examine GABAergic neurons of adult
brains in tissue sections prepared from Slc12a618/18 and WT
animals. We immunolabeled the tissue sections using GAD67
antibody to examine GABAergic neurons and presynaptic termi-
nals. However, no apparent changes in the morphology of corti-
cal or hippocampal GABAergic inhibitory neurons were detected
in either group (Fig. 5).
The observed changes in the behavioral phenotypes of both
lines also encouraged us to examine whether other members of
the KCC family with similar cotransporter activity may compen-
sate for loss of KCC3. Using Western blots of brain lysates from
Figure 5. Immunodetection analysis of GABAergic neurons of Slc12a618/18 andWT littermatemice. Brain sections of Slc12a618/18 andWT littermates (5months of age)were prepared and
immunolabeled using anti-GAD67 antibodies to label GABAergic neurons (arrows, green) and presynaptic terminals (arrowheads, green) and anti-KCC3 antibodies to label KCC3 (red) (n 3). Areas
of motor cortex were analyzed using sequential scanning by confocal microscopy. No apparent difference was observed between the two groups of mice. However, KCC3 staining was reduced and
punctated in neurons derived from Slc12a618/18mice, presumably because of the instability of the truncated protein. Nuclei were stained with TOTO-3 iodide and are shown in blue.
Table 1. Detailed quantification of the corpus callosum and anterior commissure in
Slc12a6 cKO lines (n 35)
Line Slc12a618/18 nsSlc12a618/18
CPLa (mm)
WT 8.8
 0.32 8.85
 0.27
cKO 8.9
 0.33 8.85
 0.26
p value 0.207, ns 1, ns
CCL (mm)
cKO 3.5
 0.05 3.78
 0.03
WT 3.84
 0.047 3.88
 0.03
WT– cKO 0.34 (9.3%) 0.10 (2.6%)
p value 	0.001 	0.05
CCL/CPL ratio
WT 0.44
 0.023 0.45
 0.023
cKO 0.39
 0.024 0.43
 0.017
p value 	0.001 	0.001
AC (mm2)b
cKO 0.119
 0.003 0.14
 0.004
WT 0.144
 0.0048 0.146
 0.004
WT– cKO 0.024 (18.2%) 0.006 (4.2%)
p value 	0.001 0.16, ns
AC and the CC angle
WT 45.5°
 0.32° 47.6°
 0.38°
cKO 49.1°
 0.37° 47.8°
 0.35°
cKO–WT 3.6° 0.2°
p value 	0.001 0.77
The percentage differences between cKOs and WTs were calculated using 200 (XcKO KWT )/(XcKO XWT )
formula.
aANOVA with Bonferroni correction.
bLinear regression was used to adjust commissure sizes to average brain weight (see Materials and Methods).
Mean
 SE, ns: not significant.
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Slc12a618/18 and WT animals, we tested
the expression level of KCC1, KCC2, and
KCC4 proteins, but no changes were ob-
served (data not shown).
Previous reports on conventional
KCC3 KO mice showed auditory impair-
ment (Howard et al., 2002; Boettger et al.,
2003). To assess hearing ability in our
KCC3 KO lines, we examined our mice in
startle response tests. Animals from
Slc12a6flox/flox, both KO lines, and their
WT littermates were subjected to acoustic
startle response tests, and their average
signal responses were analyzed.We found
that Slc12a618/18 animals did not re-
spond to the noise, and no increase in
startle amplitude was observed with in-
creasing intensities (Fig. 4D). However,
Slc12a6flox/flox and nsSlc12a618/18 ani-
mals did respond to increasing intensities,
as did the nontransgenic mice (Fig.
4D,E). These experiments suggest that
Slc12a618/18, but not nsSlc12a618/18
mice suffer from hearing deficiency. Inter-
estingly, the startle response baselines (at low decibels) observed in
both KO lines were higher than in the WT littermates (Fig. 4D,E),
indicating that there is a spontaneous startle in both lines while they
are inside the restrainer. Several KO animal models of cotrans-
porters such as Na-K-2Cl cotransporter 1 (NKCC1), KCC4,
and KCC3 have been shown to be hearing impaired (Delpire et al.,
1999; Boettger et al., 2002, 2003;Howard et al., 2002), but no patho-
physiological evidence was provided to separate the neuronal and
non-neuronal elements of the observed phenotypes in the KO lines.
Analysis of inflammatory pain response in Slc12a6KO mice
We tested Slc12a6flox/flox and both KCC3 KO lines on the formalin
test of spontaneous chemical/inflammatory pain. On themore clin-
ically relevant tonic/late phase of the formalin test, whereas no sig-
nificant changes were observed in Slc12a6flox/flox line (Fig. 4F), both
KOmouse lines were significantly less sensitive than their respective
WT littermates (p 	 0.05 in Slc12a618/18 and p 	 0.001 in
nsSlc12a618/18) (Fig. 4G,H). Hence, these experiments suggest
that loss of KCC3 can perturb inflammatory pain responses in both
the Slc12a618/18 and the nsSlc12a618/18 lines.
Hypoplasia of the corpus callosum in KCC3 KO mice
Although ACC is a common feature in HMSN/ACC patients, it
has not been observed in previously reported Slc12a6/ mice
(Howard et al., 2002; Boettger et al., 2003). To assess CC dysgen-
esis in our Slc12a6KO lines, we analyzed the length of the CC and
the surface area of the AC in 8-week-old Slc12a618/18 and
nsSlc12a618/18 mice and their WT littermates using gold chlo-
ride staining of midline callosal fibers (Table 1) (Fig. 6A,B). We
found that the CC length in the Slc12a618/18 KO line was sig-
nificantly reduced compared with WT littermates. A smaller but
significant decrease in the length of CC was also observed in
nsSlc12a618/18 line. The surface area measurement of the AC
also revealed a significant reduction in size but only inSlc12a618/18
animals. Furthermore, the angle at the intersection ofmid anterior–
posterior length of the CC, which was drawn to measure the CCL,
and a second line from the center of the anterior commissure
showed a significant increase in Slc12a618/18 mice, indicating a
reduction in the size of the CC and possibly a shift in its position
relative to the AC (Table 1; Fig. 6B). To determine whether the
reduction in the CC size is due to a smaller cortical plate, we mea-
sured the length of the cortical plate (CPL) in Slc12a618/18 and
nsSlc12a618/18 mice and their WT littermates, and calculated the
CPL/CCL ratio. These measurements confirmed that there is no
significant difference in the cortical plate length of both mutants,
when compared with theirWT littermates (Table 1).
To explore the possible role of KCC3 in axonal outgrowth and
elongation in vitro, axonal length of Slc12a618/18 cultured neu-
rons was measured, but no significant difference was found be-
tween Slc12a618/18 and WT neurons (Fig. 6C).
To further confirm the reduction ofCC size in the Slc12a618/18
line, we measured the total volume of the CC in Slc12a618/18,
nsSlc12a618/18, and WT littermates by diffusion-weighted MRI
(Fig. 7A). In Slc12a618/18mice, detailed quantification of the vol-
umesof the rostrum,body, and spleniumof theCCrevealed a small,
but nonsignificant, decrease in the volume of the rostrum and body
compared withWT (rostrum t 0.6316, p 0.05; body t 1.026,
p  0.05) (Fig. 7B,C). A similar volumetric observation was
made in nsSlc12a618/18 mice. Considering the entire CC, a
significant overall decrease of 12% compared with WT was
found in Slc12a618/18mice (Fig. 7C) (p 0.0019), and a signifi-
cant decrease of11%innsSlc12a618/18mice (p0.044).Hence,
decreases in the rostral components of the CC appear to contribute
to an overall reduction in the volume of the CC when measured by
MRI. Using diffusion MRI (dMRI) data, streamlines were used to
propagate pathways in the brain that are shared by regions of inter-
est, which in this case were the rostrum, body, and splenium of the
CC. While no significant differences were found in the number of
streamlines passing through each of the three CC regions in either
mutant (Fig. 7D), a qualitative decrease in streamlines was observed
in the external capsule,which includesprojections fromtheauditory
cortices, in Slc12a618/18mice (Fig. 7B,E).When streamlines from
the splenium were filtered to count only those passing through the
external capsule adjacent to the somatosensory cortices, a significant
difference in the number of streamlines was found only in the
Slc12a618/18 mice (Fig. 7E) (p 0.0325, n 3). Statistical com-
parison of fractional anisotropy and diffusivitymeasures (mean, ra-
dial, and axial diffusivity) revealed no changes in the splenium that
Figure 6. A, The corpus callosum analysis in Slc12a6 KO lines. Both Slc12a6 conditional KO lines were analyzed using gold
chloride staining of mid-sagittal cut of the brains and compared with their respective wild-type littermates (only one shown) at 8
weeks of age.B, A representativeWTbrain thatwas stained by gold chloride is shown indicating the parameters tomeasure the CC
andAC atmidline sagittal plane. C, Cortical neuronswere cultured from Slc12a618/18 andWT embryos at E15.5, and the lengths
of axons were compared.
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could account for streamline changes in the external capsule (data
not shown).
To assess the presence and integrity of growing axons crossing
themidline and in the external capsule during embryogenesis, we
used immunohistochemistry for anti-GAP-43 (Fig. 8). In both
Slc12a618/18 and nsSlc12a618/18 brains, anti-GAP-43 immu-
nohistochemistry was normal, suggesting there was no embry-
onic defect in axon growth and tract formation that could
account for the white matter changes in the adult Slc12a618/18
mouse. To establish whether there may be any cellular defects at
the midline, we used anti-GFAP immunohistochemistry to visu-
alize midline glial cells, which are known to assist midline fusion
and express axon guidance molecules (Lindwall et al., 2007).
However, in both Slc12a618/18 and nsSlc12a618/18 brains, the
formation of midline glial populations appeared normal (Fig. 8).
An additional mechanism of guidance at the cortical midline
occurs via transient neuronal populations that form the subcal-
losal sling and a cellular corridor for callosal axons to cross the
midline (Shu et al., 2003b; Niquille et al., 2009). We stained sec-
tions from both KOs andWT littermates with antibodies against
the transcription factor Nfia, which labels the subcallosal sling
(Shu et al., 2003a) and found it to be intact in both Slc12a618/18
and nsSlc12a618/18 brains (data not shown).
An alternative hypothesis for the reduction in callosal volume
may occur because of a defect in the formation of cortical neu-
rons that give rise to the callosal tract. To establish whether the
formation of cortical layers and particularly the formation of the
upper cortical layers, which give rise to the majority of callosal
axons, we examined sections stained with antibodies against
Satb2 (Alcamo et al., 2008), which labels callosal neurons, and
Nfia, which labels the corticofugal projections of the deep cortical
layers (Plachez et al., 2008). Both markers showed that the for-
mation of the cortical layers giving rise to the projection neurons
of the cerebral cortex appeared normal at P0 in both Slc12a6
18/18
and nsSlc12a618/18 brains (data not shown).
Together, these results suggest that embryonic development
of the CC is unaffected in Slc12a618/18 and nsSlc12a618/18
brains.
Discussion
KCC3 protein expression is widely detected in mouse tissues.
KCC3 consists of two main splice isoforms that are different in
their first exon. KCC3a is widely expressed in tissues such as
brain, kidney,muscle, lung, and heart, while KCC3b expression is
more limited to kidney (Hiki et al., 1999; Le Rouzic et al., 2006).
To understand themain site of cellular pathology inHMSN/ACC
and the physiological function of KCC3 in vivo, we generated two
Cre-mediated transgenic lines in which KCC3 was ablated in all
tissues or only in neuronal cells. Deletion of Slc12a6 exon 18 leads
to skipping of the exon in the mRNA, frameshifting of the open
reading frame, and premature truncation of the protein. This
leads to an unstable KCC3 protein undetectable by Western blot
in KO animals, and closelymimics the Thr813Xmutation seen in
human HMSN/ACC patients. This finding suggests that the
KCC3 C-terminal domain may be required for its trafficking or
for its stability at the plasma membrane. Indeed, tyrosine phos-
phorylation in the C-terminal domain of the closely related
KCC2was recently shown to affect KCC2 degradation andmem-
brane localization (Lee et al., 2010).Whether the truncatedKCC3
can induce lysosomal pathways or alter its trafficking remains to
be determined.
Both cKO lines developed severe neuropathy, with locomotor
and sensory deficits. The nsSlc12a618/18 mice survived longer
and had slightly greater body weights than Slc12a618/18 mice,
possibly because the nsSlc12a618/18 mice had fewer non-
neuronal deficiencies. Interestingly, the Slc12a6flox/flox mice had
Figure7. dMRI and tractography reveal subtlehypoplasia of the corpus callosum.A, Representative sagittal viewof color-codeddMRI andenlargementof a representativeCC showing the regions
of interest (ROIs) used for tractography: orange, splenium; yellow, rostrum; remaining green CC, body. The key to tissue color bidirectional orientations in the color-coded dMRI is as follows: blue,
dorsal-ventral; green,medial-lateral; red, anterior-posterior.B, Representative dorsal three-dimensional views of CC tractography inWT, Slc12a618/18, and nsSlc12a618/18 brains. Each region
of tractography has been color coded according to its seed ROI and overlaid on a two-dimensional color-coded dMRI horizontal plane at the level of the anterior commissure. A bilateral streamline
deficit appears in the external capsule (ec) of the caudal cortex of the Slc12a618/18 brain. These streamlines are adjacent to the auditory cortices. C, The number of voxels for each of the ROIs was
quantified, giving ameasure of volume, while slight, but insignificant, decreases in CC volumewere observed in the rostrum and body.When calculated for the entire CC, volumewas decreased by
12% and 11% of WTs, which were statistically significant, *p 0.0019 and *p 0.044, compared with WTs, respectively. D, Streamline number was unchanged in each of the ROIs. E, When
streamlineswere filtered to isolate those passing through the external capsule adjacent to the auditory cortex, significantly fewer streamlineswere found in the Slc12a618/18brain (*p 0.0325,
n 3, compared with WTs, t test). Values represent means
 SE. Scale bar, 1 mm in all images. post., Posterior; ant., anterior.
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no noticeable phenotype despite having
only a small fraction of the normal amount
of KCC3 protein expressed. Unlike the null
mutants, the full-lengthprotein is present in
Slc12a6flox/flox mice, evidently conferring a
necessary degree of function. This observa-
tion suggests that treatments that would re-
store only a small fraction of the normal
amount of KCC3 might be a viable treat-
ment strategy.
The crucial role of neuronal KCC3
protein in regulating peripheral
axon volume
The KCC3 cotransporter was proposed to
act predominantly as a regulator of cell
volume by passively exporting intracellu-
lar potassium and chloride (Mount et al.,
1999) by a process modulated by the
WNK1 kinase through phosphorylation
of specific sites in the C-terminal domain
(Rinehart et al., 2009). Our results show
that loss of KCC3 activity only in neurons
leads to axonal swelling and axon degen-
eration. The observed accumulation of
periaxonal fluid in nsSlc12a618/18 mice
may result from repeated axon swelling,
leading to degeneration. Hence HMSN/
ACC appears to be primarily a neuronal
disease with KCC3 playing a prominent
role in controlling axon volume. This fur-
ther suggests that in the peripheral ner-
vous system myelinating Schwann cells
may not play a prominent role in axon
swelling and the neuronal degeneration
seen in HMSN/ACC patients and previ-
ous KCC3 KO mouse models (Delpire
and Mount, 2002; Sun et al., 2010). Using
IHC, Pearson et al. (2001) have suggested
that KCC3 is expressed in white matter
tracts, but Boettger et al. (2003) reported
no LacZ staining in white matter tracts or
the corpus callosum of a LacZ-expressing KCC3 KO mouse. We
recently addressed these conflicting findings using combined in
situ hybridization and immunohistochemistry; we found no ev-
idence forKCC3 expression in oligodendrocytes (Shekarabi et al.,
2011). Overall, these results suggest that neuronal KCC3 expres-
sion is sufficient to cause axonal swelling. Our observation of
poor locomotor performance at 1 month of age suggests that the
disability is caused by early-onset progressive peripheral nerve
degeneration.
BothKCC3 andKCC4KOmice exhibit auditory impairments
due to structural defects in the organ of Corti (Boettger et al.,
2002, 2003). Interestingly, our nsSlc12a618/18 but not our
Slc12a618/18 line could respond to increasing startle pulse in-
tensities, suggesting that the auditory impairments previously
reported were not due to neuronal KCC3 loss and neurodegen-
eration in theCNS. Ablation ofNKCC1, which has amajor role in
Cl uptake, also causes deafness in mice, and this was suggested
to have a non-neuronal origin (Delpire et al., 1999; Dixon et al.,
1999). This may imply a regulatory role for KCC3 andNKCC1 in
the development and/or maintenance of non-neuronal auditory
structures or K recycling in the inner ear (Couloigner et al.,
2006). The extent of axonal degeneration in both lines also sug-
gests that the peripheral nerve axon fibers may be much more
sensitive to their osmotic environment than central axons, pos-
sibly indicating the importance of supporting cells and/or neuro-
nal environment in susceptibility of axons to degeneration.
Neuronal KCC3 deficiency may cause the
sensorimotor phenotypes
Using rotarod, beam-task, and open-field tests, wemeasuredmo-
tor abilities in both of our KCC3 KO lines. While both lines
demonstrated pronounced motor deficiencies beginning at 1
month of age, paradoxically they also both showed hyperactivity
in the open field. This finding indicates that neuronal hyperex-
citability, presumably due to chloride imbalance in the CNS, pre-
cedes a complete disability at the later age.
We used acute and tonic inflammatory pain tests to identify
potential differences between both KCC3 KO lines and their WT
littermates. A significant reduction in sensitivity to inflammatory
pain on the late-phase formalin test was observed. This suggests
that KCC3 may be important in the transmission of inflamma-
tory pain signals in CNS sensory neurons, a novel finding since
Figure 8. Immunostaining of axons and midline glial structures at E17.5 in Slc12a618/18 KO and WT mice. A, C, E, The
integrity of growing axonswas assessed using immunohistochemistry for GAP-43 in brain coronal sections from both KO lines and
WT mice. B, D, F, The three prominent midline glial populations were found to be present when visualized using immunohisto-
chemistry for GFAP. These glial populations included the indusiumgriseumglia (IGG), the glialwedge (GW), and themidline zipper
glia (MZ). Scale bar, 200m. n 3.
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KCC3 (Byun and Delpire, 2007), KCC2 (Tornberg et al., 2005),
and NKCC1 (Laird et al., 2004) mutants have never been tested
for inflammatory pain sensitivity.
Western blots using Slc12a618/18 brain lysates from our
KCC3 KO animals show no changes in expression levels of the
other KCC members, suggesting that there is no compensatory
upregulation of other KCC members (data not shown). This in-
dicates that KCC3 has a specific molecular role in cells. KCC2 is
expressed in CNS tissues (Rivera et al., 1999) where its transport
activity appears not be dependent on cell swelling, as it also op-
erates under isotonic environment (Gamba, 2005).We have pre-
viously shown that in CNS KCC3 is predominantly detected in
neurons (Shekarabi et al., 2011). This, along with our current
results, suggests that KCC3 and KCC2 may be coexpressed in
neurons but act in parallel pathways in these cells. Nonetheless,
our previous work on brain-specific creatine kinase-dependent
activation of KCC3 (Salin-Cantegrel et al., 2008) and that of oth-
ers on KCC2 (Inoue et al., 2006) suggest shared regulatory path-
ways for both cotransporter functions. However, KCC2 was
shown to function in developing synapses by interacting with the
synaptic cytoskeleton protein 4.1N independently of its Cl
transport activity, but no such an association was observed for
KCC3 (Li et al., 2007). If KCC3, like KCC2, has an independent
nontransport function, it remains to be shown (Horn et al.,
2010).
Role of KCC3 in the development of the corpus callosum
Agenesis of the CC is a common yet inconsistent observation in
HMSN/ACC patients, but is not seen in Slc12a6/null mice,
suggesting that additional genetic or extrinsic factors control this
trait. Although both our KO mouse lines retained the CC, both
mice displayed a reduction in the size and volume of the CC,
mainly in the rostrum and body. Our findings are also consistent
with the variable penetrance of ACC seen in HMSN/ACC pa-
tients. The development of the CC occurs both embryonically
and postnatally in mice and requires multiple developmental
events, including the formation of projection neurons in the ce-
rebral cortex and their extension of axons forming the corpus
callosum and their subsequent guidance by molecules expressed
by midline glial and neuronal structures (Lindwall et al., 2007).
We examined these events and found that development of the
corpus callosum appeared normal in both Slc12a618/18 and
nsSlc12a618/18 brains. The results suggest that KCC3 is more
likely to be involved in the maintenance of callosal axons
throughout life and that KCC3 may not play a significant role in
axonal outgrowth and elongation during CNS development.
The current study establishes a role forKCC3 in bothCNS and
peripheral nervous system maintenance and thus provides novel
insights into how loss of KCC3 leads to HMSN/ACC as well as
further defining its role in neuronal and non-neuronal tissues.
References
Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with Im-
ageJ. Biophotonics Int 11:36–42.
AlcamoEA,Chirivella L,DautzenbergM,DobrevaG, Farin˜as I, Grosschedl R,
McConnell SK (2008) Satb2 regulates callosal projection neuron iden-
tity in the developing cerebral cortex. Neuron 57:364–377.
BishopKM,WahlstenD (1999) Sex and species differences inmouse and rat
forebrain commissures depend on the method of adjusting for brain size.
Brain Res 815:358–366.
Boettger T, Hu¨bner CA, Maier H, Rust MB, Beck FX, Jentsch TJ (2002)
Deafness and renal tubular acidosis in mice lacking the K-Cl co-
transporter Kcc4. Nature 416:874–878.
Boettger T, Rust MB, Maier H, Seidenbecher T, Schweizer M, Keating DJ,
Faulhaber J, Ehmke H, Pfeffer C, Scheel O, Lemcke B, Horst J, Leuwer R,
Pape HC, Vo¨lkl H, Hu¨bner CA, Jentsch TJ (2003) Loss of K-Cl co-
transporter KCC3 causes deafness, neurodegeneration and reduced sei-
zure threshold. EMBO J 22:5422–5434.
Byun N, Delpire E (2007) Axonal and periaxonal swelling precede periph-
eral neurodegeneration in KCC3 knockout mice. Neurobiol Dis
28:39–51.
Couloigner V, Sterkers O, Ferrary E (2006) What’s new in ion transports in
the cochlea? Pflugers Arch 453:11–22.
DeFalco J, Tomishima M, Liu H, Zhao C, Cai X, Marth JD, Enquist L, Fried-
man JM (2001) Virus-assisted mapping of neural inputs to a feeding
center in the hypothalamus. Science 291:2608–2613.
Delpire E, Mount DB (2002) Human and murine phenotypes associated with
defects in cation-chloride cotransport. Annu Rev Physiol 64:803–843.
Delpire E, Lu J, EnglandR,Dull C, ThorneT (1999) Deafness and imbalance
associated with inactivation of the secretory Na-K-2Cl co-transporter.
Nat Genet 22:192–195.
DixonMJ, Gazzard J, Chaudhry SS, SampsonN, Schulte BA, Steel KP (1999)
Mutation of the Na-K-Cl co-transporter gene Slc12a2 results in deafness
in mice. HumMol Genet 8:1579–1584.
Dupre´ N, Howard HC, Mathieu J, Karpati G, Vanasse M, Bouchard JP, Car-
penter S, RouleauGA (2003) Hereditarymotor and sensory neuropathy
with agenesis of the corpus callosum. Ann Neurol 54:9–18.
Gamba G (2005) Molecular physiology and pathophysiology of electroneu-
tral cation-chloride cotransporters. Physiol Rev 85:423–493.
Hiki K, D’Andrea RJ, Furze J, Crawford J, Woollatt E, Sutherland GR, Vadas
MA,Gamble JR (1999) Cloning, characterization, and chromosomal lo-
cation of a novel human K-Cl- cotransporter. J Biol Chem
274:10661–10667.
Horn Z, Ringstedt T, Blaesse P, Kaila K, Herlenius E (2010) Premature ex-
pression of KCC2 in embryonic mice perturbs neural development by an
ion transport-independent mechanism. Eur J Neurosci 31:2142–2155.
HowardHC,Mount DB, Rochefort D, ByunN, Dupre´ N, Lu J, Fan X, Song L,
Rivie`re JB, Pre´vost C,Horst J, Simonati A, Lemcke B,WelchR, EnglandR,
Zhan FQ, Mercado A, Siesser WB, Beorge AL Jr, McDonald MP, et al
(2002) The K-Cl cotransporter KCC3 is mutant in a severe peripheral
neuropathy associated with agenesis of the corpus callosum. Nat Genet
32:384–392.
Inoue K, Yamada J, Ueno S, Fukuda A (2006) Brain-type creatine kinase
activates neuron-specific K-Cl- co-transporter KCC2. J Neurochem
96:598–608.
Kahle KT, Staley KJ, Nahed BV, Gamba G, Hebert SC, Lifton RP, Mount DB
(2008) Roles of the cation-chloride cotransporters in neurological dis-
ease. Nat Clin Pract Neurol 4:490–503.
Kim JH, Juraska JM (1997) Sex differences in the development of axon
number in the splenium of the rat corpus callosum from postnatal day 15
through 60. Brain Res Dev Brain Res 102:77–85.
Kim JH, EllmanA, Juraska JM (1996) A re-examination of sex differences in
axon density and number in the splenium of the rat corpus callosum.
Brain Res 740:47–56.
Korsisaari N, Rossi DJ, Paetau A, Charnay P, Henkemeyer M, Ma¨kela¨ TP
(2002) Conditional ablation of the Mat1 subunit of TFIIH in Schwann
cells provides evidence thatMat1 is not required for general transcription.
J Cell Sci 115:4275–4284.
Laird JM, García-Nicas E, Delpire EJ, Cervero F (2004) Presynaptic inhibi-
tion and spinal pain processing in mice: a possible role of the NKCC1
cation-chloride co-transporter in hyperalgesia. Neurosci Lett
361:200–203.
Langford DJ, Crager SE, Shehzad Z, Smith SB, Sotocinal SG, Levenstadt JS,
Chanda ML, Levitin DJ, Mogil JS (2006) Social modulation of pain as
evidence for empathy in mice. Science 312:1967–1970.
Lee HH, Jurd R, Moss SJ (2010) Tyrosine phosphorylation regulates the
membrane trafficking of the potassium chloride co-transporter KCC2.
Mol Cell Neurosci 45:173–179.
Le Rouzic P, Ivanov TR, Stanley PJ, Baudoin FM, Chan F, Pinteaux E, Brown
PD, Luckman SM (2006) KCC3 and KCC4 expression in rat adult fore-
brain. Brain Res 1110:39–45.
Li H, Khirug S, Cai C, Ludwig A, Blaesse P, Kolikova J, Afzalov R, Coleman
SK, Lauri S, Airaksinen MS, Keina¨nen K, Khiroug L, Saarma M, Kaila K,
Rivera C (2007) KCC2 interacts with the dendritic cytoskeleton to pro-
mote spine development. Neuron 56:1019–1033.
Lindwall C, Fothergill T, Richards LJ (2007) Commissure formation in the
mammalian forebrain. Curr Opin Neurobiol 17:3–14.
Shekarabi et al. • Neurodegeneration in a Conditional KCC3 KO Mouse J. Neurosci., March 14, 2012 • 32(11):3865–3876 • 3875
Mack CM, Boehm GW, Berrebi AS, Denenberg VH (1995) Sex differences
in the distribution of axon types within the genu of the rat corpus callo-
sum. Brain Res 697:152–160.
Mathieu J, Be´dard F, Pre´vost C, Langevin P (1990) [Motor and sensory
neuropathies with or without agenesis of the corpus callosum: a radiolog-
ical study of 64 cases]. Can J Neurol Sci 17:103–108.
Moldrich RX, Pannek K,Hoch R, Rubenstein JL, KurniawanND, Richards LJ
(2010) Comparative mouse brain tractography of diffusion magnetic
resonance imaging. Neuroimage 51:1027–1036.
MountDB,MercadoA, Song L, Xu J, George AL Jr, Delpire E, GambaG (1999)
Cloning and characterization of KCC3 and KCC4, new members of the
cation-chloride cotransporter gene family. J Biol Chem 274:16355–16362.
Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring.
Genesis 26:99–109.
Niquille M, Garel S, Mann F, Hornung JP, Otsmane B, Chevalley S, Parras C,
Guillemot F, Gaspar P, Yanagawa Y, Lebrand C (2009) Transient neu-
ronal populations are required to guide callosal axons: a role for sema-
phorin 3C. PLoS Biol 7:e1000230.
Pearson MM, Lu J, Mount DB, Delpire E (2001) Localization of the K()-
Cl(-) cotransporter, KCC3, in the central and peripheral nervous systems:
expression in the choroid plexus, large neurons and white matter tracts.
Neuroscience 103:481–491.
Plachez C, Lindwall C, SunnN, PiperM,Moldrich RX, Campbell CE, Osinski
JM, Gronostajski RM, Richards LJ (2008) Nuclear factor I gene expres-
sion in the developing forebrain. J Comp Neurol 508:385–401.
Rinehart J,MaksimovaYD,Tanis JE, StoneKL,HodsonCA,Zhang J, Risinger
M, Pan W, Wu D, Colangelo CM, Forbush B, Joiner CH, Gulcicek EE,
Gallagher PG, Lifton RP (2009) Sites of regulated phosphorylation that
control K-Cl cotransporter activity. Cell 138:525–536.
Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, Lamsa K, Pirvola U,
Saarma M, Kaila K (1999) The K/Cl- co-transporter KCC2 renders
GABA hyperpolarizing during neuronal maturation. Nature 397:251–255.
RossiDJ, LondesboroughA,KorsisaariN, PihlakA, LehtonenE,Henkemeyer
M,Ma¨kela¨ TP (2001) Inability to enter S phase and defective RNA poly-
merase II CTD phosphorylation in mice lacking Mat1. EMBO J
20:2844–2856.
Salin-Cantegrel A, Shekarabi M, Holbert S, Dion P, Rochefort D, Laganie`re J,
Dacal S,Hince P, Karemera L,GasparC, Lapointe JY, RouleauGA (2008)
HMSN/ACC truncation mutations disrupt brain-type creatine kinase-
dependant activation of K/Cl- co-transporter 3. Hum Mol Genet
17:2703–2711.
Shekarabi M, Kennedy TE (2002) The netrin-1 receptor DCC promotes
filopodia formation and cell spreading by activating Cdc42 andRac1.Mol
Cell Neurosci 19:1–17.
Shekarabi M, Girard N, Rivie`re JB, Dion P, Houle M, Toulouse A, Lafrenie`re
RG, Vercauteren F, Hince P, Laganiere J, Rochefort D, Faivre L, Samuels
M, Rouleau GA (2008) Mutations in the nervous system—specific
HSN2 exon of WNK1 cause hereditary sensory neuropathy type II. J Clin
Invest 118:2496–2505.
Shekarabi M, Salin-Cantegrel A, Laganie`re J, Gaudet R, Dion P, Rouleau GA
(2011) Cellular expression of the K()-Cl() cotransporter KCC3 in
the central nervous system of mouse. Brain Res 1374:15–26.
Shu T, Butz KG, Plachez C, Gronostajski RM, Richards LJ (2003a) Abnor-
mal development of forebrain midline glia and commissural projections
in Nfia knock-out mice. J Neurosci 23:203–212.
Shu T, Li Y, Keller A, Richards LJ (2003b) The glial sling is a migratory
population of developing neurons. Development 130:2929–2937.
Sun YT, Lin TS, Tzeng SF, Delpire E, ShenMR (2010) Deficiency of electro-
neutral K-Cl- cotransporter 3 causes a disruption in impulse propaga-
tion along peripheral nerves. Glia 58:1544–1552.
te Riele H, Maandag ER, Berns A (1992) Highly efficient gene targeting in
embryonic stem cells through homologous recombination with isogenic
DNA constructs. Proc Natl Acad Sci U S A 89:5128–5132.
Tornberg J, Voikar V, Savilahti H, Rauvala H, AiraksinenMS (2005) Behav-
ioural phenotypes of hypomorphic KCC2-deficient mice. Eur J Neurosci
21:1327–1337.
Tournier JD, Calamante F, Connelly A (2007) Robust determination of the
fibre orientation distribution in diffusion MRI: non-negativity constrained
super-resolved spherical deconvolution. Neuroimage 35:1459–1472.
Wahlsten D, Colbourne F, Pleus R (2003) A robust, efficient and flexible
method for stainingmyelinated axons in blocks of brain tissue. J Neurosci
Methods 123:207–214.
Zhu Y, RomeroMI, Ghosh P, Ye Z, Charnay P, Rushing EJ, Marth JD, Parada
LF (2001) Ablation of NF1 function in neurons induces abnormal de-
velopment of cerebral cortex and reactive gliosis in the brain. Genes Dev
15:859–876.
3876 • J. Neurosci., March 14, 2012 • 32(11):3865–3876 Shekarabi et al. • Neurodegeneration in a Conditional KCC3 KO Mouse
